User-centric, AI algorithm testing for everyone, everywhere - anvajo health is changing the in vitro diagnostic market for point-of-care testing disruptively by developing a high-quality portable device and entire analytical solution for screening and monitoring diseases, e.g. CKD. The benefits are immediate and accurate test results at economical costs for better patient's care.
Hi, this is anvajo health.
In development: The first fully integrated POC solution in the palm of your hand.
- Independency from labs
- Immediate clinical decisions
- Easy and comfortable procedure
Prof. Dr. Peter B. Luppa
Institute for Clinical Chemistry and Pathobiochemistry - Klinikum rechts der Isar
The expansion of point of care testing (POCT) in all areas of health care must be seen on a global scale. Particular attention must also be paid to the potential of POCT in developing countries. The rapid technical development of POCT analysis methods (keywords: nanotechnology, miniaturisation and parallelisation) increasingly allows even complex in vitro methods to be developed as POCT. One does not have to be a prophet to realise that the various POCT analytical methods - especially those with photonic readout procedures - are very likely to gain significant market shares due to their manifold (pre)analytical advantages.